Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Mario Kubanik - (Autor:in)
  • Wolfgang Kandioller - (Autor:in)
  • Kunwoo Kim - (Autor:in)
  • Robert Anderson - (Autor:in)
  • Erik Klapproth - , Institut für Pharmakologie und Toxikologie, Universität Wien (Autor:in)
  • Michael Jakupec - (Autor:in)
  • Alexander Roller - (Autor:in)
  • Tilo Soehnel - (Autor:in)
  • Bernhardt Keppler - (Autor:in)
  • Christian Hartinger - (Autor:in)

Abstract

Anticancer active metal complexes with biologically active ligands have the potential to interact with more than one biological target, which could help to overcome acquired and/or intrinsic resistance of tumors to small molecule drugs. In this paper we present the preparation of 2-hydroxy-[1,4]-naphthoquinone-derived ligands and their coordination to a Ru(II)(η(6)-p-cymene)Cl moiety. The synthesis of oxime derivatives resulted in the surprising formation of nitroso-naphthalene complexes, as confirmed by X-ray diffraction analysis. The compounds were shown to be stable in aqueous solution but reacted with glutathione and ascorbic acid rather than undergoing reduction. One-electron reduction with pulse radiolysis revealed different behavior for the naphthoquinone and nitroso-naphthalene complexes, which was also observed in in vitro anticancer assays.

Details

OriginalspracheEnglisch
Fachzeitschrift Dalton transactions : a journal of inorganic chemistry, including bioinorganic, organometallic, and solid-state chemistry
PublikationsstatusVeröffentlicht - 1 Aug. 2016
Peer-Review-StatusJa

Externe IDs

PubMed 27214822
Scopus 84983609803

Schlagworte